CN1213368A - 基于异羟肟酸的胶原酶抑制剂 - Google Patents
基于异羟肟酸的胶原酶抑制剂 Download PDFInfo
- Publication number
- CN1213368A CN1213368A CN97192982A CN97192982A CN1213368A CN 1213368 A CN1213368 A CN 1213368A CN 97192982 A CN97192982 A CN 97192982A CN 97192982 A CN97192982 A CN 97192982A CN 1213368 A CN1213368 A CN 1213368A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- benzyl
- group
- phenylalanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9601041.8A GB9601041D0 (en) | 1996-01-17 | 1996-01-17 | Novel compounds |
| GB9601041.8 | 1996-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1213368A true CN1213368A (zh) | 1999-04-07 |
Family
ID=10787226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97192982A Pending CN1213368A (zh) | 1996-01-17 | 1997-01-14 | 基于异羟肟酸的胶原酶抑制剂 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0912545A1 (cs) |
| JP (1) | JP2000503312A (cs) |
| KR (1) | KR19990077325A (cs) |
| CN (1) | CN1213368A (cs) |
| AR (1) | AR005472A1 (cs) |
| AU (1) | AU725056B2 (cs) |
| BR (1) | BR9707024A (cs) |
| CA (1) | CA2242913A1 (cs) |
| CZ (1) | CZ222498A3 (cs) |
| GB (1) | GB9601041D0 (cs) |
| HU (1) | HUP9901022A3 (cs) |
| IL (1) | IL125381A0 (cs) |
| NO (1) | NO983283L (cs) |
| NZ (1) | NZ326352A (cs) |
| PL (1) | PL327820A1 (cs) |
| TR (1) | TR199801380T2 (cs) |
| TW (1) | TW462967B (cs) |
| WO (1) | WO1997026257A1 (cs) |
| ZA (1) | ZA97345B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| GB9609795D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
| WO2000040713A1 (en) * | 1999-01-06 | 2000-07-13 | Mcmaster University | Method of preventing immune and hypersensitivity reactions |
| GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
| WO2002006227A1 (fr) * | 2000-07-18 | 2002-01-24 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de la metalloprotease matricielle |
| MXPA04007311A (es) * | 2002-01-28 | 2005-05-16 | Aimsco Ltd | Tratamiento de ms con suero de cabra. |
| EP1787986A4 (en) | 2004-08-10 | 2007-08-22 | Shizuoka Coffein Co Ltd | HYDROXAMINE ACID DERIVATIVE AND MEDICAMENT THEREFORE AS AN ACTIVE COMPONENT |
| KR100844277B1 (ko) * | 2005-04-29 | 2008-07-07 | (주)아모레퍼시픽 | 히드록삼산 유도체 및 이의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| GB9504084D0 (en) * | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
-
1996
- 1996-01-17 GB GBGB9601041.8A patent/GB9601041D0/en active Pending
-
1997
- 1997-01-14 EP EP97901055A patent/EP0912545A1/en not_active Withdrawn
- 1997-01-14 BR BR9707024A patent/BR9707024A/pt unknown
- 1997-01-14 TR TR1998/01380T patent/TR199801380T2/xx unknown
- 1997-01-14 HU HU9901022A patent/HUP9901022A3/hu unknown
- 1997-01-14 CZ CZ982224A patent/CZ222498A3/cs unknown
- 1997-01-14 KR KR1019980705472A patent/KR19990077325A/ko not_active Application Discontinuation
- 1997-01-14 CA CA002242913A patent/CA2242913A1/en not_active Abandoned
- 1997-01-14 AU AU14436/97A patent/AU725056B2/en not_active Ceased
- 1997-01-14 PL PL97327820A patent/PL327820A1/xx unknown
- 1997-01-14 WO PCT/EP1997/000196 patent/WO1997026257A1/en not_active Application Discontinuation
- 1997-01-14 NZ NZ326352A patent/NZ326352A/xx unknown
- 1997-01-14 JP JP9525693A patent/JP2000503312A/ja active Pending
- 1997-01-14 IL IL12538197A patent/IL125381A0/xx unknown
- 1997-01-14 CN CN97192982A patent/CN1213368A/zh active Pending
- 1997-01-15 AR ARP970100153A patent/AR005472A1/es unknown
- 1997-01-16 ZA ZA97345A patent/ZA97345B/xx unknown
- 1997-01-30 TW TW086101017A patent/TW462967B/zh active
-
1998
- 1998-07-16 NO NO983283A patent/NO983283L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9601041D0 (en) | 1996-03-20 |
| KR19990077325A (ko) | 1999-10-25 |
| AU725056B2 (en) | 2000-10-05 |
| NO983283D0 (no) | 1998-07-16 |
| EP0912545A1 (en) | 1999-05-06 |
| HUP9901022A2 (hu) | 1999-07-28 |
| ZA97345B (en) | 1998-07-16 |
| TW462967B (en) | 2001-11-11 |
| AU1443697A (en) | 1997-08-11 |
| PL327820A1 (en) | 1999-01-04 |
| CA2242913A1 (en) | 1997-07-24 |
| AR005472A1 (es) | 1999-06-23 |
| NO983283L (no) | 1998-09-16 |
| IL125381A0 (en) | 1999-03-12 |
| NZ326352A (en) | 2000-03-27 |
| WO1997026257A1 (en) | 1997-07-24 |
| HUP9901022A3 (en) | 2001-11-28 |
| JP2000503312A (ja) | 2000-03-21 |
| CZ222498A3 (cs) | 1999-03-17 |
| BR9707024A (pt) | 1999-07-20 |
| TR199801380T2 (xx) | 1998-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060167044A1 (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
| CN1305473A (zh) | 抑制整联蛋白与其受体结合的n,n－二取代的酰胺 | |
| CN1251091A (zh) | 新化合物 | |
| CN1228775A (zh) | 作为时间生物学药物的苯并呋喃和苯并吡喃 | |
| CN113950471A (zh) | 带电的离子通道阻滞剂及其使用方法 | |
| JP2004067699A (ja) | 新規化合物 | |
| CN1213368A (zh) | 基于异羟肟酸的胶原酶抑制剂 | |
| JP2000510473A (ja) | ｓ―ＣＤ２３生成およびＴＮＦ分泌の阻害剤 | |
| ES2574277T3 (es) | Derivados de dibenzotiazepina y su uso en el tratamiento de trastornos del SNC | |
| JPH10502656A (ja) | ヒトｓ−ｃｄ２３の阻害剤の使用 | |
| JP3922431B2 (ja) | 可溶性ヒトｃｄ２３形成阻害剤としてのヒドロキサム酸誘導体 | |
| EP1844775B1 (en) | Therapeutic agent for the treatment of herpes progenitalis after development of lesions | |
| JP2005513036A (ja) | キノリン誘導体、それらの製造方法、ならびにｓ−ＣＤ２３により媒介される障害の治療におけるそれらの使用 | |
| JP2002518470A (ja) | ヒトｃｄ２３の産生およびその放出の阻害剤としてのヒドロキサム酸誘導体 | |
| JP2000510138A (ja) | ヒドロキサム酸をベースとするｃｄ２３およびｔｎｆ形成の阻害剤 | |
| JPH06107562A (ja) | 腎臓病の治療に有用な医薬組成物 | |
| US20020082200A1 (en) | Use of inhibitors of human S-CD23 | |
| JPWO2003072545A1 (ja) | 環状アミン化合物及びそれを有効成分とするｃｃｒ３阻害薬 | |
| EP0909169A1 (en) | Medical use | |
| JP2003519211A (ja) | Ｃｄ２３形成の阻害剤として使用のための２−，３−アミノ−４−（ｎ−ヒドロキシアミノ）−スクシニルアミノ−アセトアミド | |
| JP2005513034A (ja) | スルホン誘導体ならびに自己免疫疾患およびアレルギーの治療におけるその使用 | |
| CZ341799A3 (cs) | Deriváty hydroxamové kyseliny substituované aryl- nebo heteroarylsulfonamidem, způsob jejich přípravy a jejich použití jako léčivých přípravků |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |